---
document_datetime: 2025-12-29 12:30:00
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/trogarzo.html
document_name: trogarzo.html
version: success
processing_time: 0.108199
conversion_datetime: 2025-12-31 07:48:37.389718
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Trogarzo

[RSS](/en/individual-human-medicine.xml/67243)

##### Withdrawn

This medicine's authorisation has been withdrawn

ibalizumab Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Trogarzo](#news-on)
- [More information on Trogarzo](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 1 January 2023, the European Commission withdrew the marketing authorisation for Trogarzo (ibalizumab) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Theratechnologies Europe Limited, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Trogarzo was granted marketing authorisation in the EU on 26 September 2019 for the treatment of adults infected with multidrug resistant HIV-1 infection for whom it is otherwise not possible to construct a suppressive antiviral regimen. The marketing authorisation was initially valid for a 5-year period.

The European Public Assessment Report (EPAR) for Trogarzo is updated to indicate that the marketing authorisation is no longer valid.

Trogarzo : EPAR - Medicine overview

Reference Number: EMA/502446/2019

English (EN) (665.94 KB - PDF)

**First published:** 10/10/2019

**Last updated:** 16/01/2023

[View](/en/documents/overview/trogarzo-epar-medicine-overview_en.pdf)

[Other languages (22)](#file-language-dropdown-139)

български (BG) (729.99 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/bg/documents/overview/trogarzo-epar-medicine-overview_bg.pdf)

español (ES) (657.7 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/es/documents/overview/trogarzo-epar-medicine-overview_es.pdf)

čeština (CS) (716.14 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/cs/documents/overview/trogarzo-epar-medicine-overview_cs.pdf)

dansk (DA) (656.3 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/da/documents/overview/trogarzo-epar-medicine-overview_da.pdf)

Deutsch (DE) (663.12 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/de/documents/overview/trogarzo-epar-medicine-overview_de.pdf)

eesti keel (ET) (73.34 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/et/documents/overview/trogarzo-epar-medicine-overview_et.pdf)

ελληνικά (EL) (763.57 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/el/documents/overview/trogarzo-epar-medicine-overview_el.pdf)

français (FR) (662.39 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/fr/documents/overview/trogarzo-epar-medicine-overview_fr.pdf)

hrvatski (HR) (679.34 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/hr/documents/overview/trogarzo-epar-medicine-overview_hr.pdf)

italiano (IT) (656.3 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/it/documents/overview/trogarzo-epar-medicine-overview_it.pdf)

latviešu valoda (LV) (716.2 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/lv/documents/overview/trogarzo-epar-medicine-overview_lv.pdf)

lietuvių kalba (LT) (680.41 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/lt/documents/overview/trogarzo-epar-medicine-overview_lt.pdf)

magyar (HU) (728.36 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/hu/documents/overview/trogarzo-epar-medicine-overview_hu.pdf)

Malti (MT) (724.22 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/mt/documents/overview/trogarzo-epar-medicine-overview_mt.pdf)

Nederlands (NL) (657.17 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/nl/documents/overview/trogarzo-epar-medicine-overview_nl.pdf)

polski (PL) (714.21 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/pl/documents/overview/trogarzo-epar-medicine-overview_pl.pdf)

português (PT) (660.99 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/pt/documents/overview/trogarzo-epar-medicine-overview_pt.pdf)

română (RO) (681.06 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/ro/documents/overview/trogarzo-epar-medicine-overview_ro.pdf)

slovenčina (SK) (715.17 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/sk/documents/overview/trogarzo-epar-medicine-overview_sk.pdf)

slovenščina (SL) (708.72 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/sl/documents/overview/trogarzo-epar-medicine-overview_sl.pdf)

Suomi (FI) (656.28 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/fi/documents/overview/trogarzo-epar-medicine-overview_fi.pdf)

svenska (SV) (656.95 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/sv/documents/overview/trogarzo-epar-medicine-overview_sv.pdf)

Trogarzo : EPAR - Risk-management-plan summary

English (EN) (667.56 KB - PDF)

**First published:** 10/10/2019

**Last updated:** 16/01/2023

[View](/en/documents/rmp-summary/trogarzo-epar-risk-management-plan-summary_en.pdf)

## Product information

Trogarzo : EPAR - Product Information

English (EN) (1.15 MB - PDF)

**First published:** 10/10/2019

**Last updated:** 16/01/2023

[View](/en/documents/product-information/trogarzo-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-852)

български (BG) (1.74 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/bg/documents/product-information/trogarzo-epar-product-information_bg.pdf)

español (ES) (1.16 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/es/documents/product-information/trogarzo-epar-product-information_es.pdf)

čeština (CS) (1.6 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/cs/documents/product-information/trogarzo-epar-product-information_cs.pdf)

dansk (DA) (997.86 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/da/documents/product-information/trogarzo-epar-product-information_da.pdf)

Deutsch (DE) (1.02 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/de/documents/product-information/trogarzo-epar-product-information_de.pdf)

eesti keel (ET) (301.99 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/et/documents/product-information/trogarzo-epar-product-information_et.pdf)

ελληνικά (EL) (1.68 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/el/documents/product-information/trogarzo-epar-product-information_el.pdf)

français (FR) (1014.56 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/fr/documents/product-information/trogarzo-epar-product-information_fr.pdf)

hrvatski (HR) (1.05 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/hr/documents/product-information/trogarzo-epar-product-information_hr.pdf)

íslenska (IS) (922.11 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/is/documents/product-information/trogarzo-epar-product-information_is.pdf)

italiano (IT) (1.01 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/it/documents/product-information/trogarzo-epar-product-information_it.pdf)

latviešu valoda (LV) (1.54 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/lv/documents/product-information/trogarzo-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.1 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/lt/documents/product-information/trogarzo-epar-product-information_lt.pdf)

magyar (HU) (1.49 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/hu/documents/product-information/trogarzo-epar-product-information_hu.pdf)

Malti (MT) (1.52 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/mt/documents/product-information/trogarzo-epar-product-information_mt.pdf)

Nederlands (NL) (1.01 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/nl/documents/product-information/trogarzo-epar-product-information_nl.pdf)

norsk (NO) (1.03 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/no/documents/product-information/trogarzo-epar-product-information_no.pdf)

polski (PL) (1.42 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/pl/documents/product-information/trogarzo-epar-product-information_pl.pdf)

português (PT) (1 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/pt/documents/product-information/trogarzo-epar-product-information_pt.pdf)

română (RO) (1.1 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/ro/documents/product-information/trogarzo-epar-product-information_ro.pdf)

slovenčina (SK) (1.43 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/sk/documents/product-information/trogarzo-epar-product-information_sk.pdf)

slovenščina (SL) (1.37 MB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/sl/documents/product-information/trogarzo-epar-product-information_sl.pdf)

Suomi (FI) (1017 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/fi/documents/product-information/trogarzo-epar-product-information_fi.pdf)

svenska (SV) (960.21 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/sv/documents/product-information/trogarzo-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IAIN/0020 12/10/2022

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Trogarzo : EPAR - All authorised presentations

English (EN) (598.16 KB - PDF)

**First published:** 10/10/2019

**Last updated:** 16/01/2023

[View](/en/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-644)

български (BG) (624.09 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/bg/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_bg.pdf)

español (ES) (580.88 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/es/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_es.pdf)

čeština (CS) (612.33 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/cs/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (580.45 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/da/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (580.84 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/de/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (9.68 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/et/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (623.37 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/el/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_el.pdf)

français (FR) (580.53 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/fr/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (595.43 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/hr/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (599.47 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/is/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_is.pdf)

italiano (IT) (580.88 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/it/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (616.44 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/lv/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (595.46 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/lt/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (602.71 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/hu/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (614.78 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/mt/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (580.63 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/nl/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (600.04 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/no/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_no.pdf)

polski (PL) (613.79 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/pl/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_pl.pdf)

português (PT) (580.71 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/pt/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_pt.pdf)

română (RO) (597.59 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/ro/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (611.37 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/sk/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (602.75 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/sl/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (580.44 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/fi/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (580.68 KB - PDF)

**First published:**

10/10/2019

**Last updated:**

16/01/2023

[View](/sv/documents/all-authorised-presentations/trogarzo-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Trogarzo Active substance Ibalizumab International non-proprietary name (INN) or common name ibalizumab Therapeutic area (MeSH) HIV Infections Anatomical therapeutic chemical (ATC) code J05AX

### Pharmacotherapeutic group

Antivirals for systemic use

### Therapeutic indication

Trogarzo, in combination with other antiretroviral(s), is indicated for the treatment of adults infected with multidrug resistant HIV-1 infection for whom it is otherwise not possible to construct a suppressive antiviral regimen.

## Authorisation details

EMA product number EMEA/H/C/004961 Marketing authorisation holder

Theratechnologies Europe Limited

4th Floor

Opinion adopted 25/07/2019 Marketing authorisation issued 26/09/2019 Withdrawal of marketing authorisation 01/01/2023 Revision 7

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Trogarzo : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (997.53 KB - PDF)

**First published:** 23/03/2020

**Last updated:** 16/01/2023

[View](/en/documents/procedural-steps-after/trogarzo-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Trogarzo : EPAR - Public assessment report

Adopted

Reference Number: EMA/469134/2019

English (EN) (4.2 MB - PDF)

**First published:** 10/10/2019

**Last updated:** 16/01/2023

[View](/en/documents/assessment-report/trogarzo-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Trogarzo

Adopted

Reference Number: EMA/CHMP/85932/2019

English (EN) (705.5 KB - PDF)

**First published:** 26/07/2019

**Last updated:** 16/01/2023

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-trogarzo_en.pdf)

#### News on Trogarzo

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 July 2019](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-july-2019) 26/07/2019

#### More information on Trogarzo

- [EMEA-002311-PIP01-17-M02 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-002311-pip01-17-m02)

**This page was last updated on** 16/01/2023

## Share this page

[Back to top](#main-content)